Coloplast A/S (CPH:COLO.B)

Revenue

Financials in millions DKK. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013
Ostomy Care Revenue	9.90B	9.55B
Ostomy Care Revenue Growth	3.69%	5.77%
Continence Care Revenue	8.98B	8.54B
Continence Care Revenue Growth	5.20%	7.31%
Chronic Care Revenue	18.88B	18.09B
Chronic Care Revenue Growth	4.40%	6.49%
Voice and Respiratory Care Revenue	2.28B	2.11B
Voice and Respiratory Care Revenue Growth	8.06%	8.82%
Interventional Urology Revenue	2.78B	2.78B
Interventional Urology Revenue Growth	0.32%	3.78%
Advanced Wound Dressings Revenue	2.68B	3.03B
Advanced Wound Dressings Revenue Growth	-11.83%	7.21%
Biologics Revenue	1.25B	1.03B
Biologics Revenue Growth	22.22%	1268.00%
Advanced Wound Care Revenue	3.93B	4.06B
Advanced Wound Care Revenue Growth	-3.23%	39.76%
Revenue (Total)	27.87B	27.03B
Revenue (Total) Growth	3.12%	10.33%

Revenue by Geography

Financials in millions DKK. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013
European Markets Revenue	15.51B	14.75B
European Markets Revenue Growth	5.15%	6.05%
Other Developed Markets Revenue	7.83B	7.75B
Other Developed Markets Revenue Growth	1.06%	19.54%
Emerging Markets Revenue	4.54B	4.53B
Emerging Markets Revenue Growth	0.04%	10.26%
Revenue (Total)	27.87B	27.03B
Revenue (Total) Growth	3.12%	10.33%

EBIT

Financials in millions DKK. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013
Chronic Care Segment EBIT	11.06B	10.44B
Chronic Care Segment EBIT Growth	5.96%	6.44%
Voice and Respiratory Care Segment EBIT	837.00M	736.00M
Voice and Respiratory Care Segment EBIT Growth	13.72%	10.51%
Interventional Urology Segment EBIT	984.00M	976.00M
Interventional Urology Segment EBIT Growth	0.82%	3.06%
Advanced Wound Dressings Segment EBIT	1.11B	1.15B
Advanced Wound Dressings Segment EBIT Growth	-4.16%	7.86%
Biologics Segment EBIT	159.00M	101.00M
Biologics Segment EBIT Growth	57.43%	1022.22%
Advanced Wound Care Segment EBIT	1.26B	1.25B
Advanced Wound Care Segment EBIT Growth	0.80%	16.33%
Operating Income (Total)	7.20B	7.32B
Operating Income (Total) Growth	-1.63%	8.11%

Key Performance Indicators

Financials in millions DKK. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013
Ostomy Care Organic Growth	6.00%	7.00%
Continence Care Organic Growth	8.00%	8.00%
Voice and Respiratory Care Organic Growth	9.00%	11.00%
Advanced Wound Care Organic Growth	8.00%	10.00%
Interventional Urology Organic Growth	2.00%	5.00%
Total Organic Growth	7.00%	8.00%

Updated Sep 30, 2025. Data Source: Fiscal.ai.